Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3000
-0.11-27.01%
Last update: Dec 16, 9:30 AM
Comments
Loading...
Akari Therapeutics (AKTX) Stock Price, Quote, News & History
AKTXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akari Therapeutics (AKTX) stock?
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Who are Akari Therapeutics (AKTX) competitors?
Other companies in Akari Therapeutics’s space includes: Curis Inc (NASDAQ:CRIS), Cellectar Biosciences Inc (NASDAQ:CLRB), Imunon Inc (NASDAQ:IMNN), Edesa Biotech Inc (NASDAQ:EDSA) and AIxCrypto Holdings Inc (NASDAQ:AIXC).
What is the forecast, or price target, for Akari Therapeutics (AKTX) stock?
Akari Therapeutics has a consensus price target of $3.30.
What is the current price for Akari Therapeutics (AKTX)?
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $0.3 last updated December 16, 2025 at 9:30 AM EST.
Does Akari Therapeutics (AKTX) pay a dividend?
There are no upcoming dividends for Akari Therapeutics.
When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?
Akari Therapeutics does not have any upcoming earnings scheduled.
Is Akari Therapeutics (AKTX) going to split?
There is no upcoming split for Akari Therapeutics.
What sector and industry does Akari Therapeutics (AKTX) operate in?
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
